CDT Equity (CDT) Current Assets (2021 - 2026)
CDT Equity's (CDT) quarterly Current Assets came in at $3.1 million in Q1 2026, down 48.7% YoY from $5.9 million in Q1 2025, and down 30.3% on a QoQ basis from $4.4 million in Q4 2025.
CDT Equity (CDT) Current Assets (2021 - 2026) Analysis & Trends
CDT Equity (CDT) has 6 years of Current Assets data on file, last reported at $3.1 million in Q1 2026.
- Quarterly Current Assets fell 48.7% year-over-year to $3.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.1 million (down 48.7% YoY) and the FY2025 annual result came in at $4.4 million, up 61.29% from the prior year.
- Current Assets fell to $3.1 million in Q1 2026, from $4.4 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $10.4 million in Q3 2023 to a low of $501000.0 in Q1 2023.
- A 5-year average of $3.4 million and a median of $2.7 million in 2024 frame the typical range for Current Assets.
- Annual changes were most pronounced in 2023 — Current Assets surged 810.88% — and 2024, when it plunged 86.62%.
- Tracing CDT's Current Assets over 5 years: stood at $646639.0 in 2022, then soared by 786.58% to $5.7 million in 2023, then sank by 52.64% to $2.7 million in 2024, then soared by 61.29% to $4.4 million in 2025, then plunged by 30.3% to $3.1 million in 2026.
- The last three Current Assets figures came in at $3.1 million (Q1 2026), $4.4 million (Q4 2025), and $7.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 8.07 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 5.82 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 7.22 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 4.62 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 18.80 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 1.63 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.76 Bn |
| 10 | CDT Equity | 1.55 Mn | 1.55 Mn | - | 2.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.94 Mn |
| Mar 31, 2026 | 3.05 Mn |
| Dec 31, 2025 | 4.38 Mn |
| Sep 30, 2025 | 7.09 Mn |
| Jun 30, 2025 | 6.39 Mn |
| Mar 31, 2025 | 5.95 Mn |
| Dec 31, 2024 | 2.72 Mn |
| Sep 30, 2024 | 1.40 Mn |
| Jun 30, 2024 | 1.60 Mn |
| Mar 31, 2024 | 3.16 Mn |
| Dec 31, 2023 | 5.73 Mn |
| Sep 30, 2023 | 10.44 Mn |
| Jun 30, 2023 | 895,000.00 |
| Mar 31, 2023 | 501,000.00 |
| Dec 31, 2022 | 646,639.00 |
| Sep 30, 2022 | 1.15 Mn |
| Jun 30, 2022 | 1.33 Mn |
| Mar 31, 2022 | 1.45 Mn |
| Dec 31, 2021 | 104,163.00 |